Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1992 Feb;260(2):768-72.

Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans

Affiliations
  • PMID: 1738122
Comparative Study

Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans

J J Beutler et al. J Pharmacol Exp Ther. 1992 Feb.

Abstract

The effect of intravenous administration of the loop diuretics bumetanide, furosemide and ethacrynic acid on lithium (Li) clearance (CLi) and diluting segment reabsorption was studied in seven healthy water-loaded men. According to the increments in minimal urine osmolality (Uosm), ethacrynic acid (which increased Uosm from 59 +/- 4 to 233 +/- 3 mOsmol/kg) had the strongest inhibiting effect on diluting segment reabsorption, whereas that of furosemide and especially bumetanide was significantly less pronounced (rise in Uosm from 56 +/- 3 to 222 +/- 4 and 56 +/- 4 to 192 +/- 2 mOsmol/kg, respectively). In contrast, ethacrynic acid induced a significantly smaller rise in CLi (approximately 14% of the filtered load of Li) than furosemide and bumetanide, which increased Li excretion by approximately 23% and approximately 24% of its filtered load. The observation that the loop diuretic with the most pronounced inhibiting effect in the diluting segment had the smallest effect on CLi makes is unlikely that the increase in CLi induced by loop diuretics is predominantly effected in Henle's loop.

PubMed Disclaimer

Similar articles

Cited by

  • Renal lymphatic vessel dynamics.
    Shelton EL, Yang HC, Zhong J, Salzman MM, Kon V. Shelton EL, et al. Am J Physiol Renal Physiol. 2020 Dec 1;319(6):F1027-F1036. doi: 10.1152/ajprenal.00322.2020. Epub 2020 Oct 26. Am J Physiol Renal Physiol. 2020. PMID: 33103446 Free PMC article.
  • Decongestion in heart failure: medical and device therapies.
    Cox ZL, Damman K, Testani JM. Cox ZL, et al. Nat Rev Cardiol. 2025 Apr 28. doi: 10.1038/s41569-025-01152-z. Online ahead of print. Nat Rev Cardiol. 2025. PMID: 40295876 Review.
  • Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure.
    Rao VS, Planavsky N, Hanberg JS, Ahmad T, Brisco-Bacik MA, Wilson FP, Jacoby D, Chen M, Tang WHW, Cherney DZI, Ellison DH, Testani JM. Rao VS, et al. J Am Soc Nephrol. 2017 Nov;28(11):3414-3424. doi: 10.1681/ASN.2016111178. Epub 2017 Jul 24. J Am Soc Nephrol. 2017. PMID: 28739647 Free PMC article.
  • Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.
    Griffin M, Rao VS, Ivey-Miranda J, Fleming J, Mahoney D, Maulion C, Suda N, Siwakoti K, Ahmad T, Jacoby D, Riello R, Bellumkonda L, Cox Z, Collins S, Jeon S, Turner JM, Wilson FP, Butler J, Inzucchi SE, Testani JM. Griffin M, et al. Circulation. 2020 Sep 15;142(11):1028-1039. doi: 10.1161/CIRCULATIONAHA.120.045691. Epub 2020 May 15. Circulation. 2020. PMID: 32410463 Free PMC article. Clinical Trial.

Publication types

LinkOut - more resources